Mink Therapeutics Inc Cash Flow-to-Debt Ratio
Mink Therapeutics Inc cash flow-to-debt ratio. Mink Therapeutics Inc (INKT) has a Cash Flow-to-Debt Ratio of -0.09x as of June 2026, meaning its operating cash flow of $-2.08 Million could theoretically repay 0% of its total liabilities ($23.64 Million) in one year. See INKT financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Mink Therapeutics Inc (2019–2025)
Cash flow-to-debt ratio of Mink Therapeutics Inc from 2019 to 2025. Historical debt coverage capacity for Mink Therapeutics Inc across 7 annual periods. Also explore Mink Therapeutics Inc net asset momentum to track the company's year-over-year net asset growth rate.
Mink Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2019–2025)
Mink Therapeutics Inc cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Mink Therapeutics Inc. For the full cash flow conversion analysis, see INKT cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.21x | $-5.93 Million | $28.47 Million | ▲ +44.9% |
| 2024 | -0.38x | $-9.56 Million | $25.31 Million | ▲ +45.8% |
| 2023 | -0.70x | $-15.76 Million | $22.61 Million | ▲ +19.2% |
| 2022 | -0.86x | $-18.87 Million | $21.87 Million | ▼ -10.7% |
| 2021 | -0.78x | $-12.83 Million | $16.47 Million | ▼ -445.9% |
| 2020 | -0.14x | $-8.34 Million | $58.43 Million | ▲ +64.1% |
| 2019 | -0.40x | $-14.94 Million | $37.64 Million | — |